It is also very interesting that approximately 50% of patients discontinued biologic treatment due to remission, although elsewhere, only around 9–13% of JIA patients discontinued TNFα inhibitors due to remission12,14,16. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.